Hepatic Encephalopathy
Hepatic Encephalopathy (HE) is a neurological disorder resulting from severe liver disease, wherein the liver's inability to remove toxins from the blood leads to symptoms such as confusion, forgetfulness, personality changes, movement problems, and in advanced stages, coma. The condition can manifest gradually or suddenly, significantly impacting brain function.
Health Outcomes
- Accelerated Recovery in Immunocompromised Mice
- Altered Plasma Metabolite Levels
- Attenuated Hepatic Disorders
- Changed Alkaline Phosphatase Level
- Elevated Acetic Acid Levels
- Elevated Lactate Levels
- Elevated Serum Enzyme Levels
- Improved Alanine Aminotransferase Level
- Improved Alcohol-Associated Liver Disease Parameters
- Improved Bilirubin Level
- Improved CST Status to CST I
- Improved Child-Pugh Scores
- Improved Chronic Alcohol-Induced Liver Injury
- Improved Detoxification
- Improved Detoxification Pathway
- Improved Enzyme Activity
- Improved Enzyme Levels (ADH, ALDH)
- Improved Glasgow Coma Scale Score
- Improved Growth in Bile-Containing Medium
- Improved Hepatic Damage
- Improved Hepatic Disease
- Improved Hepatic Encephalopathy
- Improved Hepatic Oxidative Stress
- Improved Liver Antioxidant Capacity
- Improved Liver Disease Biomarkers
- Improved Liver Enzyme Function
- Improved Liver Enzyme Level
- Improved Liver Health
- Improved Liver Metabolic Pathways
- Improved Liver Regeneration
- Improved Minimal Hepatic Encephalopathy
- Improved Nitrogen Balance
- Improved Psychometric Hepatic Encephalopathy Score
- Improved Resistance to Ammonia Nitrogen Stress
- Improved Serum Protein Levels
- Improved Survival Rate in Digestive Conditions
- Improvement in Alcoholic Liver Disease
- Increased Degradation of Non-Assimilated Compounds
- Increased Dose Tolerance
- Increased Drug Bioavailability
- Increased Occurrence of Serious Adverse Events
- Increased Parabenzoylaminobenzoic Acid Concentration
- Increased Portal Endotoxin Levels
- Increased Serum Total Bile Acid Levels
- Increased Survival Rate of Alcohol-Treated Cells
- Increased Thermoplasma Abundance
- Increased Vitamin K Level
- Maintained Albumin Levels
- Maintained Cell Viability in Low pH
- Maintained Normal ALT Levels
- Maintained Normal Liver Function
- Maintained pH Levels
- Modulated Metabolite Profile
- Prevention of Alcoholic Liver Disease
- Prolonged INR
- Reduced Acetaminophen Intake
- Reduced Acute Liver Injury
- Reduced Alcohol-Induced Liver Injury
- Reduced Ammonia Concentration
- Reduced Ammonia Excretion
- Reduced Ammonia Levels
- Reduced Aspartate Transaminase Activity
- Reduced Blood Ammonia Levels
- Reduced Blood Urea Nitrogen Levels
- Reduced Butyrylcholinesterase Activity
- Reduced Child-Pugh Score
- Reduced Choline Level
- Reduced Chronic Liver Disease Severity
- Reduced Confusion
- Reduced Decompensation
- Reduced Dimethyl Sulfide Level
- Reduced Encephalopathy
- Reduced Fecal Ammonia Levels
- Reduced Ferroptosis
- Reduced Fresh Frozen Plasma Transfusion
- Reduced GPT Level
- Reduced Gamma-Glutamyl Transferase Levels
- Reduced Gastrointestinal Microbial Fermentation-Related Intoxication
- Reduced Hepatic Enzyme Level
- Reduced Hepatotoxicity
- Reduced Hunger Sensation
- Reduced Incidence of Abnormal Increase in Alkaline Phosphatase
- Reduced Indoxyl Sulfate Levels
- Reduced Isoleucine Level
- Reduced Levels of Toxic Amines
- Reduced Liver Biochemical Markers
- Reduced Liver Damage Indicators
- Reduced Liver Disease Symptoms
- Reduced Liver Function
- Reduced Liver Function Indicators
- Reduced Liver Injury
- Reduced Liver Injury Indicators
- Reduced Liver Toxicity
- Reduced Liver Transplantation Requirement
- Reduced MELD Score
- Reduced Methylphenidate Dosing Requirement
- Reduced Microbial Translocation to the Liver
- Reduced Organ Dysfunction
- Reduced Pathological Changes of Liver
- Reduced Plasma Ammonia Levels
- Reduced Plasma Urea Level
- Reduced Portal Vein LPS Levels
- Reduced Prothrombin Level
- Reduced Prothrombin Time
- Reduced S-Adenosylmethionine Level
- Reduced Serpin Level
- Reduced Serum Alanine Aminotransferase Activity
- Reduced Serum Ammonia Levels
- Reduced Stool Ammonia Concentration
- Reduced Sulfur Compound Level
- Reduced Toxin-induced Cytotoxicity
- Reduced Urea Level
- Reduced Urinary p-Cresol Excretion
- Regulated Liver Metabolite Levels
- Stabilized Total Bilirubin Levels